- Home
- GAMB vs ALMS Comparison
GAMB vs ALMS Comparison
Compare GAMB & ALMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAMB
- ALMS
- Stock Information
- Founded
- GAMB 2006
- ALMS 2021
- Country
- GAMB Jersey
- ALMS United States
- Employees
- GAMB N/A
- ALMS N/A
- Industry
- GAMB Services-Misc. Amusement & Recreation
- ALMS
- Sector
- GAMB Consumer Discretionary
- ALMS
- Exchange
- GAMB Nasdaq
- ALMS NYSE
- Market Cap
- GAMB 567.6M
- ALMS 469.0M
- IPO Year
- GAMB 2021
- ALMS 2024
- Fundamental
- Price
- GAMB $14.63
- ALMS $5.17
- Analyst Decision
- GAMB Strong Buy
- ALMS Strong Buy
- Analyst Count
- GAMB 7
- ALMS 7
- Target Price
- GAMB $16.29
- ALMS $28.83
- AVG Volume (30 Days)
- GAMB 554.6K
- ALMS 280.9K
- Earning Date
- GAMB 03-20-2025
- ALMS 03-07-2025
- Dividend Yield
- GAMB N/A
- ALMS N/A
- EPS Growth
- GAMB 306.73
- ALMS N/A
- EPS
- GAMB 0.78
- ALMS N/A
- Revenue
- GAMB $124,404,000.00
- ALMS N/A
- Revenue This Year
- GAMB $18.40
- ALMS N/A
- Revenue Next Year
- GAMB $33.09
- ALMS N/A
- P/E Ratio
- GAMB $18.86
- ALMS N/A
- Revenue Growth
- GAMB 27.63
- ALMS N/A
- 52 Week Low
- GAMB $7.52
- ALMS $4.74
- 52 Week High
- GAMB $17.14
- ALMS $13.53
- Technical
- Relative Strength Index (RSI)
- GAMB 44.14
- ALMS N/A
- Support Level
- GAMB $14.80
- ALMS N/A
- Resistance Level
- GAMB $17.14
- ALMS N/A
- Average True Range (ATR)
- GAMB 0.93
- ALMS 0.00
- MACD
- GAMB -0.08
- ALMS 0.00
- Stochastic Oscillator
- GAMB 37.87
- ALMS 0.00
About GAMB Gambling.com Group Limited
Gambling.com Group Ltd is a multi-award-winning performance marketing company and a provider of digital marketing services in the online gambling industry. Its principal focus is on online casino and online sports betting and the fantasy sports industry. It generates revenue by referring online gamblers to online gambling operators.
About ALMS ALUMIS INC
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.